Publications on oral peptide delivery

List of Gattefossé publications on peptide delivery.

A proof-of-concept for developing oral lipidized peptide Nanostructured Lipid Carrier formulations

Camille Dumont, Vincent Jannin, Cédric Miolane, Quentin Lelong, Jean-Pierre Valour, Sebastien Urbaniak, Hatem Fessib, Sandrine Bourgeois

Journal of Drug Delivery Science and Technology (article in press)

In this study, the authors developed a protocol to produce reproducible solid lipid nanoparticles by high pressure homogeneization. The possibility to encapsulate peptides was also investigated.

Access the publication

In Vitro Studies Indicate Promising Properties Of Solid Lipid Nanosuspensions for oral peptide delivery

Camille Dumont, Ana Beloqui, Sandrine Bourgeois, Véronique Préat, Hatem Fessi, Vincent Jannin

Poster CRS 2019

Download the poster

In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract

Camille Dumont, Sandrine Bourgeois, Hatem Fessib, Pierre-Yves Dugas, Vincent Jannin

International Journal of Pharmaceutics, Volume 565, 30 June 2019, Pages 409-418

Access the publication

Lipid-based nanosuspensions for oral delivery of peptides, a critical review

Camille Dumont, Sandrine Bourgeois, Hatem Fessi, Vincent Jannin

International Journal of Pharmaceutics, Volume 541, Issues 1–2, 25 April 2018, Pages 117–135
 
In this review article, the authors describe:
  • the different techniques used to prepare Solid Lipid Nanoparticles and Nanostructured Lipid Carriers
  • the methods used to assess the protective effects of the carriers on peptides
  • the techniques used to measure the permeability enhancement

Self-emulsifying peptide drug delivery systems: How to make them highly mucus permeating

Janine Griesser, Gergely Hetényi, Hatice Kadas, Frédéric Demarne, Vincent Jannin and Andreas Bernkop-Schnürch

International Journal of Pharmaceutics, Volume 538, Issues 1–2, 1 March 2018, Pages 159-166

The aim of this study was to evaluate the mucus permeating properties of self-emulsifying drug delivery systems (SEDDS). Small droplet size and negative zeta potential of SEDDS could be identified as key parameters for their mucus permeating properties.

 

Access the publication

Comparison of the protective effect of self-emulsifying peptide drug delivery systems towards intestinal proteases and glutathione

Gergely Hetényi, Janine Griesser, Michael Moser, Frédéric Demarne, Vincent Jannin, Andreas Bernkop-Schnürch.

International Journal of Pharmaceutics, Volume 523, Issue 1, 15 May 2017, Pages 357–365 This study shows that independent from the type of peptide all the SEDDS showed a prolonged release and can provide a 100% protective effect towards protease degradation and deactivation by reduced glutathione.

 

Access the publication

Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems

Janine Griesser, Gergely Hetényi, Michael Moser, Frédéric Demarne, Vincent Jannin, Andreas Bernkop-Schnürch.

International Journal of Pharmaceutics, Volume 520, Issues 1–2, 30 March 2017, Pages 267–274 In this study, hydrophobic ion pairing is used to form complexes between different anionic surfactants and leuprorelin, insulin and desmopression as model peptides. These complexes were formulated in SEDDS and evaluated for payload and stability.

 

Access the publication